Pearson (PSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those ...

He said any positive developments were likely to drive market recovery, particularly given the improved diplomatic status of ...

Pakistan is facing a sharp rise in fuel import costs as Middle East war disruptions drive diesel premiums to record highs.

Zasocitinib, which is a potent and highly selective TYK2 inhibitor would be a good option for some of our patients who are ...

Public Service Co. of Oklahoma has applied to the state Corporation Commission for an “adjustment” in its rates that would ...

A Meta data center is coming to east Tulsa. Meta will pay all energy costs and usage, and taxes will not be raised to cover ...

Using the Canadian Hydrogen Intensity Mapping Experiment (CHIME), an international team of astronomers has performed radio ...

Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...

Pakistan Stock Exchange (KSE-100) surges amid hopes for US-Iran talks in Islamabad. Saudi aid & Eurobond issuance also boost ...

Conversations are underway between Gov. Greg Abbott and Houston Mayor John Whitmire after the Houston City Council voted to ...

Almost 120 suburban train stations will no longer be manned by protective service officers in a bid to ramp up security at ...